In CHC patients since none of the miRNAs tested was significantly deregulated in serum, we followed the expression of the miRNAs that were deregulated in the liver and/or those almost significantly differentially expressed in serum samples of patients with F3-F4 compared to those with F0-F1-F2.
← all excerpts
MicroRNA-based diagnostic tools for advanced fibrosis and cirrhosis in patients with chronic hepatitis B and C.
1
—
—